Cargando…
A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2
Currently, the world is facing a pandemic of the new coronavirus SARS-CoV-2 that causes COVID-19. Identifying key targets in the viral infection lifecycle is urgently needed for designing therapeutic strategies to combat the virus. Furin is a subtilisin-like proprotein convertase with diverse cellul...
Autores principales: | Devi, Kasi Pandima, Pourkarim, Mahmoud Reza, Thijssen, Marijn, Sureda, Antoni, Khayatkashani, Maryam, Cismaru, Cosmin Andrei, Neagoe, Ioana Berindan, Habtemariam, Solomon, Razmjouei, Soha, Khayat Kashani, Hamid Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760129/ https://www.ncbi.nlm.nih.gov/pubmed/35031970 http://dx.doi.org/10.1007/s43440-021-00344-x |
Ejemplares similares
-
Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do?
por: Nabavi, Seyed Fazel, et al.
Publicado: (2020) -
Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19
por: Manayi, Azadeh, et al.
Publicado: (2021) -
Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
por: Habtemariam, Solomon, et al.
Publicado: (2020) -
Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID‐19: Shoot the messenger!
por: Habtemariam, Solomon, et al.
Publicado: (2020) -
Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?
por: Dowran, Razieh, et al.
Publicado: (2020)